Explore HCV and Drug User Health Center of Excellence Learning Pathways (LP)
Providing Care to LGBTQ+ People who Use Drugs (Online)
Description:
This five-part learning pathway will provide attendees with knowledge on providing high quality stigma-free and affirming care to LGBTQ+ people who use drugs. It will cover a variety of topics including: key principles of providing culturally informed and responsive treatment to LGBTQ+ individuals with substance use disorders (SUDs); discuss the role of stimga, bias and oppression in healthcare access and outcomes among people who use drugs; describe inclusive and affirming ways to obtain medical and social histories from LGBTQ+ people who use drugs; describe barriers and ways to overcome them when delivering clinical care to transgender and gender expansive people who use drugs; and discuss clinical management for LGBTQ+ people who use drugs, including treatment initiation, dosing adjustments and best practices. All trainings in this learning pathway are one-hour in length and offer free continuing education credit. Attendees will recieve a Pathway Certificate of Completion after completing the series.
Trainings Included:
- Engaging LGBTQ+ People who Use Drugs: Cultural Responsiveness and Beyond
- Addressing Stigma and Bias in Health Care for LGBTQ+ People who Use Drugs
- Creating an LGBTQ+ Affirming Practice for People who Use Drugs
- Caring for Transgender and Gender Expansive People who Use Drugs
- Case Studies on LGBTQ+ People who Use Drugs
Click here to register
Foundations of Buprenorphine for Opioid Use Disorder (Online)
Description:
This three-part learning pathway will provide attendees with knowledge on how to prescribe buprenorphine in New York State. It will cover the goals and principles of buprenorphine treatment for opioid use disorder as well as training requirements in order to prescribe buprenorphine. This pathway will discuss the pharmacology of buprenorphine as compared with other medications for opioid use disorder and review best practice for initiation, dose stabilization, maintenance and discontinuation. It will provide case studies to illustrate how buprenorphine treatment can be delivered in various clinical settings. Attendees will receive a Pathway Certification of Completion after completing the series.
Trainings Included:
- Buprenorphine Prescribing for Beginners
- Buprenorphine Initiation for Beginners
- Buprenorphine in Practice: A Case-based Discussion
Click here to register
Trainings to Satisfy the DEA Education Mandate (Online)
Description:
In June 2023, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of eight hours of training on the treatment and management of patients with opioid or other substance use disorder for practitioners who are applying for or renewing their DEA license. As an ACCME-accredited organization, CEI recommends the following courses to meet the DEA requirement.
Refer to official communication from the DEA and SAMHSA for more information:
- https://deadiversion.usdoj.gov/pubs/docs/MATE_Training_Letter_Final.pdf
- https://www.samhsa.gov/substance-use/treatment/statutes-regulations-guidelines/mate-act/curricular-elements-training
Trainings Included:
- Strategies to Prevent Overdose in New York State: A Harm Reduction Framework
- Buprenorphine Prescribing for Beginners
- Clinical Practice Guidelines for the Treatment of Alcohol Use Disorder
- Tobacco Use Disorder Treatment among People Who Use Drugs
- Stimulant Use Disorder: Clinical Practice Guidelines for the Primary Care Provider
- Pain Management for People Who Use Opioids
- Integrating Harm Reduction into Every Clinical Encounter
- Xylazine: What Clinicians Need to Know